Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$247K
Net Open-Market Flow
-$247K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Option exercise(M)6K$1.80$11K393K
Feb 17, 2026Sell(S)2K$29.59$65K387K
Feb 17, 2026Sell(S)5K$28.95$156K389K
Feb 17, 2026Sell(S)900$28.02$25K395K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2026Option exercise(M)6K$088K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-059883) within minutes of acceptance. Every field above traces to the original document. Verify it directly: